Hideyuki Akaza - My portal - researchmap

Profile Information

Affiliation: Professor, Former Institution / Organization University of Tsukuba Graduate School of Comprehensive Human Sciences

Degree: 医学博士(東京大学)

J-GLOBAL ID: 200901020228155704
researchmap Member ID: 1000048897

External link: http://www.md.tsukuba.ac.jp/public/clinical-med/urology/

Research Interests

2

Research Areas

1

Life sciences / Urology /

Research History

11

1997

- 筑波大学臨床医学系泌尿器科教授
1997

- Professor of the University of Tsukuba, Institute of Clinical Medicine
1990 - 1996

Institute of Clinical Medicine, University of Tsukuba
1990 - 1996

Associate Professor of the University of Tsukuba
1986 - 1990

東京大学医学部泌尿器科講師
1986 - 1990

Lecturer of the University of Tokyo
1981 - 1986

東京大学医学部泌尿器科助手
1982

- テネシー大学(USA)泌尿器科客員助教授
1982

- Visiting assistant professor of University of Tennessee
1977 - 1980

東京大学医学部泌尿器科助手
1974 - 1975

東京大学医学部泌尿器科助手

Education

2

Committee Memberships

7

Awards

6

Misc.

611

Real-time Elastography for the Diagnosis of Prostate Cancer: Evaluation of Elastographic Moving Images

Tomoaki Miyagawa, Masakazu Tsutsumi, Takeshi Matsumura, Natsui Kawazoe, Satoru Ishikawa, Tatsuro Shimokama, Naoto Miyanaga, Hideyuki Akaza

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39(6) 394-398, Jun, 2009
Real-time Elastography for the Diagnosis of Prostate Cancer: Evaluation of Elastographic Moving Images

Tomoaki Miyagawa, Masakazu Tsutsumi, Takeshi Matsumura, Natsui Kawazoe, Satoru Ishikawa, Tatsuro Shimokama, Naoto Miyanaga, Hideyuki Akaza

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39(6) 394-398, Jun, 2009
Evidence-based clinical practice guidelines for renal cell carcinoma (Summary - JUA 2007 Edition)

Tomoaki Fujioka, Wataru Obara

International Journal of Urology, 16(4) 339-353, Apr, 2009
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association

Eiji Kikuchi, Hiroyuki Fujimoto, Yoichi Mizutani, Eijiro Okajima, Hiroshi Koga, Shiro Hinotsu, Nobuo Shinohara, Mototsugu Oya, Tsuneharu Miki

INTERNATIONAL JOURNAL OF UROLOGY, 16(3) 279-286, Mar, 2009
Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-GuErin

Akira Joraku, Atthachai Homhuan, Koji Kawai, Takahiro Yamamoto, Jun Miyazaki, Kentaro Kogure, Ikuya Yano, Hideyoshi Harashima, Hideyuki Akaza

BJU INTERNATIONAL, 103(5) 686-693, Mar, 2009
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association

Eiji Kikuchi, Hiroyuki Fujimoto, Yoichi Mizutani, Eijiro Okajima, Hiroshi Koga, Shiro Hinotsu, Nobuo Shinohara, Mototsugu Oya, Tsuneharu Miki

INTERNATIONAL JOURNAL OF UROLOGY, 16(3) 279-286, Mar, 2009
Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-GuErin

Akira Joraku, Atthachai Homhuan, Koji Kawai, Takahiro Yamamoto, Jun Miyazaki, Kentaro Kogure, Ikuya Yano, Hideyoshi Harashima, Hideyuki Akaza

BJU INTERNATIONAL, 103(5) 686-693, Mar, 2009
Bladder cancer develops 6 years earlier in current smokers: Analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association

Shiro Hinotsu, Hideyuki Akaza, Tsuneharu Miki, Hiroyuki Fujimoto, Nobuo Shinohara, Eiji Kikuchi, Yoichi Mizutani, Hirofumi Koga, Eijiro Okajima, Akihiko Okuyama

INTERNATIONAL JOURNAL OF UROLOGY, 16(1) 64-69, Jan, 2009
Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling

T. Kojima, T. Shimazui, S. Hinotsu, A. Joraku, T. Oikawa, K. Kawai, R. Horie, H. Suzuki, R. Nagashima, K. Yoshikawa …

ONCOGENE, 28(2) 297-305, Jan, 2009
DECREASE IN PROLIFERATION AND INCREASE IN DIFFERENTIATION IS ACCOMPANIED WITH LOW APAF-1 PROTEIN EXPRESSION IN TESTICULAR GERM CELL TUMOR PATHWAY

ElsevierJ Urol, 181(supl 1-4) 200-201, 2009
EXPRESSION OF CADHERIN-6 MRNA IS POOR PROGNOSTIC FACTOR FOR PATIENTS WITH T1-T3 RENAL CELL CARCINOMA

ElsevierJ Urol, 181(supl 1-4) 216-217, 2009
IDENTIFICATION OF PRETREATMENT PROGNOSTIC FACTOR FOR PATIENTS WITH INTERMEDIATE- AND POOR-RISK METASTATIC TESTICULAR CANCER

ElsevierJ Urol, 181(supl 1-4) 198, 2009
FORKHEAD TRANSCRIPTION FACTOR FOXO1 IS INVOLVED IN PROGRESSION OF RENAL CELL CARCINOMA

J Urol, 181(Supl 1-4) 106, 2009
RISK ASSESSMENT AMONG PROSTATE CANCER PATIENTS MANAGED WITH PRIMARY ANDROGEN DEPRIVATION THERAPY: A TRANSPACIFIC STUDY

ElsevierJ Urol, 181(Supl 4-1) 103, 2009
Evidence-based clinical practice guidelines for renal cell carcinoma (Summary – JUA 2007 Edition)

Wiley InterScienceInt J Urol, 16(4) 339-353, 2009
Bladder cancer develops 6 years earlier in current smokers: Analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association

Shiro Hinotsu, Hideyuki Akaza, Tsuneharu Miki, Hiroyuki Fujimoto, Nobuo Shinohara, Eiji Kikuchi, Yoichi Mizutani, Hirofumi Koga, Eijiro Okajima, Akihiko Okuyama

INTERNATIONAL JOURNAL OF UROLOGY, 16(1) 64-69, Jan, 2009
Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling

T. Kojima, T. Shimazui, S. Hinotsu, A. Joraku, T. Oikawa, K. Kawai, R. Horie, H. Suzuki, R. Nagashima, K. Yoshikawa …

ONCOGENE, 28(2) 297-305, Jan, 2009
DECREASE IN PROLIFERATION AND INCREASE IN DIFFERENTIATION IS ACCOMPANIED WITH LOW APAF-1 PROTEIN EXPRESSION IN TESTICULAR GERM CELL TUMOR PATHWAY

ElsevierJ Urol, 181(supl 1-4) 200-201, 2009
EXPRESSION OF CADHERIN-6 MRNA IS POOR PROGNOSTIC FACTOR FOR PATIENTS WITH T1-T3 RENAL CELL CARCINOMA

ElsevierJ Urol, 181(supl 1-4) 216-217, 2009
IDENTIFICATION OF PRETREATMENT PROGNOSTIC FACTOR FOR PATIENTS WITH INTERMEDIATE- AND POOR-RISK METASTATIC TESTICULAR CANCER

ElsevierJ Urol, 181(supl 1-4) 198, 2009

More

Books and Other Publications

60

PROSTATE CANCER Edition 2006

6th International Consultation on New Developments in Prostate Cancer and Prostate Diseases [Editions 21], 2006
Developments in Cancer Epidemiology -Prospects for cancer control in the Asian pacific- [Extended abstracts for the 36th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 2005]

the Princess Takamatsu Cancer Research Fund, 2006
PROSTATE CANCER Edition 2006

6th International Consultation on New Developments in Prostate Cancer and Prostate Diseases [Editions 21], 2006
Developments in Cancer Epidemiology -Prospects for cancer control in the Asian pacific- [Extended abstracts for the 36th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 2005]

the Princess Takamatsu Cancer Research Fund, 2006
Prostate Cancer: 3rd International Consultation of Prostate Cancer - Paris

Health Publications (distributor: Editions21), 2003
Prostate Cancer: 3rd International Consultation of Prostate Cancer - Paris

Health Publications (distributor: Editions21), 2003
Proceedings 2nd International Consultation on Prostate Cancer

Health Publication Ltd., 2000
Proceedings 2nd International Consultation on Prostate Cancer

Health Publication Ltd., 2000
Kidney cancer. recent results of basic and clinical research

Contrib Nephrol, 1999
Kidney cancer. recent results of basic and clinical research

Contrib Nephrol, 1999
Serum Creatinine Level during Chemotherapy for Testicular Cancer as a Possible Predictor of Bleomycin-induced Pulmonary Toxicity(共著)

In : Germ Cell Tumours IV, The Proceedings of the Fourth Germ Cell Tumour Conference, Published by : John Libbey & Co. Ltd., 1998
4th International Consultation on Benign prostatic hyperplasia (BPH) Paris, July 2-5, 1997: Proceedings 4

Health Publication Ltd., 1998
Serum Creatinine Level during Chemotherapy for Testicular Cancer as a Possible Predictor of Bleomycin-induced Pulmonary Toxicity(jointly worked)

In : Germ Cell Tumours IV, The Proceedings of the Fourth Germ Cell Tumour Conference, Published by : John Libbey & Co. Ltd., 1998
4th International Consultation on Benign prostatic hyperplasia (BPH) Paris, July 2-5, 1997: Proceedings 4

Health Publication Ltd., 1998
Food Factors for Cancer Prevention

Springer, 1997
Food Factors for Cancer Prevention

Springer, 1997
BCG intravesical instillation therapy as a first choice modality for existing sperficial bladder cancer

4th International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment Proceedings 4, Scientific Communication International Ltd., 1995
Cancer chemotherapy : Challenges for the future volume 10

Excerpta Medica, Ltd., 1995
BCG intravesical instillation therapy as a first choice modality for existing sperficial bladder cancer

4th International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment Proceedings 4, Scientific Communication International Ltd., 1995
Cancer chemotherapy : Challenges for the future volume 10

Excerpta Medica, Ltd., 1995

More

Professional Memberships

23

More

Research Projects

8

前立腺癌のリスク評価と化学予防

科学研究費補助金
前立腺癌の環境・宿主要因に関する疫学的研究

科学研究費補助金
膀胱癌とBCGおよびBLP
前立腺癌の発癌に関する研究
膀胱癌の発癌に関する研究
Bladder cancer and BCG and BLP
Study of carcinogenesis of prostote cancer
Study of carcinogenesis of bladder cancer